Birdwatch Note Rating
2023-08-27 05:27:34 UTC - NOT_HELPFUL
Rated by Participant: 3A07E68E2C3AEEABF16C97168BADD33D1C6FB0B3AF5D8F8328CEE487341E8C28
Participant Details
Original Note:
EBC-46 has shown efficacy to reduce cancer in animal studies only. Clinical trials have since commenced for skin, head and neck, and soft tissue cancers in humans. In 2020 the FDA approved an EBC-46–based medication Stelfonta, to treat mast cell cancer in dogs. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/
All Note Details